|
SRRM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.699580E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.221700E-02 |
| Normal-vs-Stage2 |
5.771000E-01 |
| Normal-vs-Stage3 |
5.487800E-01 |
| Normal-vs-Stage4 |
5.134000E-01 |
| Stage1-vs-Stage2 |
6.518000E-01 |
| Stage1-vs-Stage3 |
3.472000E-01 |
| Stage1-vs-Stage4 |
8.515400E-01 |
| Stage2-vs-Stage3 |
8.998600E-01 |
| Stage2-vs-Stage4 |
8.652600E-01 |
| Stage3-vs-Stage4 |
7.452200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.443800E-01 |
| Normal-vs-AfricanAmerican |
1.178640E-01 |
| Normal-vs-Asian |
4.730400E-02 |
| Caucasian-vs-AfricanAmerican |
4.206600E-01 |
| Caucasian-vs-Asian |
2.880200E-01 |
| AfricanAmerican-vs-Asian |
4.588600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.454500E-02 |
| Normal-vs-Female |
8.472600E-01 |
| Male-vs-Female |
1.144030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.146400E-01 |
| Normal-vs-Extreme_Weight |
2.206000E-02 |
| Normal-vs-Obese |
9.179800E-01 |
| Normal-vs-Extreme_Obese |
1.007170E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.722400E-01 |
| Normal_Weight-vs-Obese |
1.657390E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.342400E-01 |
| Extreme_Weight-vs-Obese |
2.375800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.548000E-01 |
| Obese-vs-Extreme_Obese |
2.591400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.887200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.689000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.220200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.018100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.877800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.820420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.082600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.580500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.561600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.264300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.552400E-01 |
| Normal-VS-Type2 PRCC |
7.795900E-03 |
| Normal-VS-KIRP CIMP |
7.820400E-01 |
| Normal-VS-Unclassified PRCC |
6.901400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.172330E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.416600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.455600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.633620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.139300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.561600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.296400E-02 |
| Normal-vs-N1 |
7.577400E-01 |
| Normal-vs-N2 |
3.121800E-01 |
| N0-vs-N1 |
6.179600E-02 |
| N0-vs-N2 |
8.833600E-01 |
| N1-vs-N2 |
4.679000E-01 |
|
|
